Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ruddy

Showing results (381-390 of 400) with videos related to

Pageof 40
Sort By:
Breast Cancer Research : BCR|May 1, 2025
Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohortsKristen D Brantley, Michael E Jones, Rulla M Tamimi, et al.
Breast Cancer Research and Treatment|June 13, 2021
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)Kathryn J Ruddy, Yue Zheng, Nabihah Tayob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPTPaolo Tarantino, Nabihah Tayob, Guillermo Villacampa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2023
International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 CohortsIain R Timmins, Michael E Jones, Katie M O'Brien, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 21, 2024
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021Sherry-Ann Brown, Craig Beavers, Brenton Bauer, et al.
JAMA|December 7, 2023
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort StudyMatteo Lambertini, Eva Blondeaux, Elisa Agostinetto, et al.
Scientific Reports|April 28, 2018
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association ConsortiumHisani N Horne, Hannah Oh, Mark E Sherman, et al.
Scientific Reports|April 14, 2022
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 womenXiaoliang Wang, Pooja Middha Kapoor, Paul L Auer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer RiskLenka Stolarova, Petra Kleiblova, Petra Zemankova, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Pageof 40

Showing results (381-390 of 400) with videos related to

Sort By:
Pageof 40
Breast Cancer Research : BCR|May 1, 2025
Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohortsKristen D Brantley, Michael E Jones, Rulla M Tamimi, et al.
Breast Cancer Research and Treatment|June 13, 2021
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)Kathryn J Ruddy, Yue Zheng, Nabihah Tayob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2024
Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPTPaolo Tarantino, Nabihah Tayob, Guillermo Villacampa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2023
International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 CohortsIain R Timmins, Michael E Jones, Katie M O'Brien, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 21, 2024
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021Sherry-Ann Brown, Craig Beavers, Brenton Bauer, et al.
JAMA|December 7, 2023
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort StudyMatteo Lambertini, Eva Blondeaux, Elisa Agostinetto, et al.
Scientific Reports|April 28, 2018
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association ConsortiumHisani N Horne, Hannah Oh, Mark E Sherman, et al.
Scientific Reports|April 14, 2022
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 womenXiaoliang Wang, Pooja Middha Kapoor, Paul L Auer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer RiskLenka Stolarova, Petra Kleiblova, Petra Zemankova, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Pageof 40